Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidović, Milena Rikalović
Cells (2022) Vol. 11, Iss. 11, pp. 1732-1732
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 57
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 50
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 29
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub, Md Minarul Islam, Seong‐Tshool Hong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 15
Salivary Biomarkers for Parkinson’s Disease: A Systematic Review with Meta-Analysis
Kacper Nijakowski, Wojciech Owecki, Jakub Jankowski, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 340-340
Open Access | Times Cited: 9
Porous Materials for Early Diagnosis of Neurodegenerative Diseases
Payam Arghavani, Hossein Daneshgar, Soheil Sojdeh, et al.
Advanced Healthcare Materials (2025)
Closed Access | Times Cited: 1
Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease
JS Thakur, Angel Godad
Life Sciences (2025) Vol. 363, pp. 123376-123376
Closed Access | Times Cited: 1
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
The roles of intrinsically disordered proteins in neurodegeneration
Kagistia Hana Utami, Satoru Morimoto, Yasue Mitsukura, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130772-130772
Open Access | Times Cited: 1
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
The Role of Hydrogen Sulfide (H2S) in Epigenetic Regulation of Neurodegenerative Diseases: A Systematic Review
Bombonica Gabriela Dogaru, Constantin Munteanu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12555-12555
Open Access | Times Cited: 21
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
Lluís Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 541-541
Open Access | Times Cited: 20
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
Ana Sofía Vallés, Francisco J. Barrantes
Cells (2023) Vol. 12, Iss. 16, pp. 2051-2051
Open Access | Times Cited: 19
Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products
Kailin Yang, Liuting Zeng, Jinsong Zeng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102063-102063
Closed Access | Times Cited: 17
Research progress of PROTACs for neurodegenerative diseases therapy
Zhifang Cai, Zunhua Yang, Huilan Li, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107386-107386
Closed Access | Times Cited: 8
Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders
Narges Naimi, Homa Seyedmirzaei, Zahra Hassannejad, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116691-116691
Open Access | Times Cited: 8
Lewy body radius growth: The hypothesis of the cube root of time dependency
A. V. Kuznetsov
Journal of Theoretical Biology (2024) Vol. 581, pp. 111734-111734
Open Access | Times Cited: 7
Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson’s disease through anti-oxidant capacities
Rabia Anjum, Chand Raza, Mehwish Faheem, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0302102-e0302102
Open Access | Times Cited: 7
Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathways
Tanzeer Kaur, Palak Sidana, Navpreet Kaur, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2801-2820
Closed Access | Times Cited: 6
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 6
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167930-167930
Open Access | Times Cited: 25
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease
Tanatcha Sanguanphun, Sukrit Promtang, Nilubon Sornkaew, et al.
Marine Drugs (2023) Vol. 21, Iss. 3, pp. 141-141
Open Access | Times Cited: 13
The major histocompatibility complex participates in Parkinson’s disease
Rou Gu, Jianyu Pan, Maher Un Nisa Awan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107168-107168
Open Access | Times Cited: 4
Modulation of conformational integrity and aggregation propensity of α-synuclein by osmolytes: Implications in therapeutic intervention of Parkinson’s disease
Ishfaq Ahmad Ahanger, Ishfaq Bashir Hajam, Owais Hassan Wani
Progress in molecular biology and translational science (2025), pp. 63-87
Closed Access
Page 1 - Next Page

Scroll to top